Levo-Anawin 0.25% (Levobupivacaine Vials) 0.25% x 20ml

Levo-Anawin 0.25% is a local anesthetic solution containing levobupivacaine, designed for pain management. It provides targeted numbing effects for medical procedures. This 0.25% strength in 20ml vials is commonly used in clinical settings. Suitable for short-term pain relief during minor surgeries or diagnostic procedures.

Strength

0.25% x 20ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Neon Laboratories LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Levo-Anawin 0.25% is used to numb specific areas of the body during medical procedures, providing localized pain relief. It is often employed for minor surgeries, dental work, or diagnostic tests where temporary loss of sensation is required. This solution helps manage discomfort during interventions without affecting consciousness.

Side Effects

Levo-Anawin 0.25% works by blocking nerve signals in the targeted area, temporarily reducing sensation. Users may experience a gradual onset of numbness, which can last for the duration of the procedure. The effects are localized and do not typically cause systemic side effects when used as directed.

Precautions & Warnings

Handle Levo-Anawin 0.25% with care to avoid accidental exposure or contamination. Store in a cool, dry place away from direct sunlight. Always follow medical guidance for administration to minimize risks. Ensure the solution is clear and free of particles before use.

Avoid Interactions

Levo-Anawin 0.25% may interact with other medications that affect heart rhythm or blood pressure. Caution is advised when used alongside drugs metabolized by certain liver enzymes. Alcohol or sedatives may enhance drowsiness. Always disclose all medications to your healthcare provider before use.

References

Frequently Asked Questions

Levo-Anawin 0.25% is used for localized numbing during medical procedures, such as minor surgeries or dental work.

The duration of numbness varies but typically lasts for the length of the procedure and a short time afterward.

No, this medication is intended for use by healthcare professionals in clinical settings only.

Seek immediate medical attention if you notice unusual symptoms after administration.

Consult a healthcare provider before using any medication during pregnancy to assess potential risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.